Stephen Morlock, Director at BioPharmX Corp (BPMX), sold 1,564,126 shares at $0.19 ($290K) on 2018-10-18, disclosed to the SEC on 2018-10-22.
Open-market sale of $290k BPMX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.19 | 439,099 | $83K | 28.7% |
| 2 | $0.19 | 439,099 | $83K | 28.7% |
| 3 | $0.18 | 214,091 | $39K | 13.3% |
| 4 | $0.18 | 220,766 | $40K | 13.7% |
| 5 | $0.18 | 251,071 | $45K | 15.6% |
| Total | $0.19 avg | 1,564,126 |
| $290K |
| 100% |
| Filing → |
| BPMX | BUY | 2016-01-15 | $18K | — | Filing → |
| BPMX | BUY | 2016-01-12 | $9K | — | Filing → |
| BPMX | BUY | 2016-01-11 | $7K | — | Filing → |